Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

  • Read more about A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

RTMS for the Treatment of Post-COVID Associated Affective Symptoms

  • Read more about RTMS for the Treatment of Post-COVID Associated Affective Symptoms

Huahui Health Ltd.

By jpalfreyman on Mon, 12/02/2024 - 10:05
  • Read more about Huahui Health Ltd.

A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

  • Read more about A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine

  • Read more about Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine

Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19

  • Read more about Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19

Bio-reconfigurable Electronic Platform for Multiplex Detection of Viral Respiratory Pathogens

  • Read more about Bio-reconfigurable Electronic Platform for Multiplex Detection of Viral Respiratory Pathogens

Optimizing Clinical Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-edge Repair (M-TEER) for Severe Functional Mitral Regurgitation Towards Improved Guideline-directed Medical Therapy

  • Read more about Optimizing Clinical Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-edge Repair (M-TEER) for Severe Functional Mitral Regurgitation Towards Improved Guideline-directed Medical Therapy

Supportive Training After Cardiac Rehabilitation Including Virtual Engagement

  • Read more about Supportive Training After Cardiac Rehabilitation Including Virtual Engagement

Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance

  • Read more about Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Current page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA